As of 2024-12-13, the Relative Valuation of Cassava Sciences Inc (SAVA) is (6.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.79 USD, the upside of Cassava Sciences Inc based on Relative Valuation is -345.1%.
The range of the Relative Valuation is (3.86) - (9.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 25.3x | 18.5x |
| Forward P/E multiples | 10.0x - 25.9x | 18.6x |
| Fair Price | (3.86) - (9.31) | (6.84) |
| Upside | -238.3% - -433.6% | -345.1% |
| Date | P/E |
| 2024-12-11 | -7.74 |
| 2024-12-10 | -7.85 |
| 2024-12-09 | -7.99 |
| 2024-12-06 | -8.75 |
| 2024-12-05 | -8.31 |
| 2024-12-04 | -8.01 |
| 2024-12-03 | -9.10 |
| 2024-12-02 | -9.36 |
| 2024-11-29 | -10.43 |
| 2024-11-27 | -10.81 |
| 2024-11-26 | -10.39 |
| 2024-11-25 | -11.67 |
| 2024-11-22 | -71.93 |
| 2024-11-21 | -87.41 |
| 2024-11-20 | -70.76 |
| 2024-11-19 | -76.06 |
| 2024-11-18 | -75.92 |
| 2024-11-15 | -73.09 |
| 2024-11-14 | -71.00 |
| 2024-11-13 | -68.40 |
| 2024-11-12 | -71.65 |
| 2024-11-11 | -73.50 |
| 2024-11-08 | -73.20 |
| 2024-11-07 | -68.83 |
| 2024-11-06 | -72.17 |
| 2024-11-05 | -65.00 |
| 2024-11-04 | -70.19 |
| 2024-11-01 | -71.19 |
| 2024-10-31 | -70.09 |
| 2024-10-30 | -70.62 |
| 2024-10-29 | -72.04 |
| 2024-10-28 | -72.61 |
| 2024-10-25 | -72.12 |
| 2024-10-24 | -74.13 |
| 2024-10-23 | -76.03 |
| 2024-10-22 | -77.22 |
| 2024-10-21 | -78.45 |
| 2024-10-18 | -78.77 |
| 2024-10-17 | -80.33 |
| 2024-10-16 | -80.48 |
| 2024-10-15 | -76.76 |
| 2024-10-14 | -74.70 |
| 2024-10-11 | -70.08 |
| 2024-10-10 | -67.53 |
| 2024-10-09 | -67.91 |
| 2024-10-08 | -70.76 |
| 2024-10-07 | -69.02 |
| 2024-10-04 | -73.56 |
| 2024-10-03 | -73.23 |
| 2024-10-02 | -73.18 |